28 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
previously announced registered direct offering to a single healthcare-focused institutional investor of an aggregate of 3,571,429 ordinary shares
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
28 May 24
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
8:13am
Exhibit 99.1
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
Single healthcare-focused institutional investor
$5 … company, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale
6-K
ENLV
Enlivex Therapeutics Ltd
28 May 24
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
8:13am
into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale in a registered direct offering of an aggregate
6-K
EX-99.1
9vh 2qktjn5kywutr0dn
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
7ao177
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
6-K
EX-99.1
sk5op8arzk76cdkm
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-99.2
sw8b6656 2v
5 Mar 20
Report of Foreign Private Issuer
8:16am
20-F/A
3xvhtmtfuec70gsb7p
23 Jan 20
Annual report (foreign) (amended)
4:31pm
UPLOAD
4mc9fauml4 8h9gq9g
3 Jul 19
Letter from SEC
12:00am
UPLOAD
95z6el txcv20m
13 Jun 19
Letter from SEC
12:00am
6-K
EX-99.1
dp4l887zf
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
nzs4g x8ff
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
5qm10q1phrqgda6
26 Jul 18
Bioblast Pharma Ltd. Corporate and Management Update
4:35pm